Addyi Reviews 2024. Disorder of low sexual desire. Medically reviewed by philip thornton, dippharm.
Addyi (flibanserin) received an overall rating of 5 out of 10 stars from 3 reviews. The fda is considering possible regulatory action, due to a spike in reported adverse events associated with the drug addyi (flibanserin), which is indicated for hypoactive sexual desire disorder.
Last Updated On Aug 22, 2023.
25% of reviewers reported a positive experience, while 63%.
What Is The Most Important Information I Should Know About Addyi (Flibanserin)?
Reviewed by medicine.com on february 3, 2020.
21 People Found This Comment Helpful.
Images References :
Reviewed By Medicine.com On February 3, 2020.
Decreased libido is a common symptom of the menopause transition, and the most.
Former Employee, More Than 3 Years.
I would not recommend it.
Addyi Has An Average Rating Of 3.8 Out Of 10 From A Total Of 68 Ratings On Drugs.com.